IL-4 and IL-13 Induce SOCS-1 Gene Expression in A549 Cells by Three Functional STAT6-Binding Motifs Located Upstream of the Transcription Initiation Site

Journal of Immunology

Volumn 171, Issue 11, 2003, Pages 5901-5907

  Hebenstreit, Daniel ^a   Luft, Petra ^a   Schmiedlechner, Angela ^a   Regl, Gerhard ^a   Frischauf, Anna Maria ^a   Aberger, Fritz ^a   Duschl, Albert ^a   Horejs Hoeck, Jutta ^a  

^a UNIVERSITY OF SALZBURG   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 4; LUCIFERASE; STAT6 PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CELL LINE; CONTROLLED STUDY; ENZYME ACTIVITY; GEL MOBILITY SHIFT ASSAY; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; REPORTER GENE; SUPPRESSOR OF CYTOKINE SIGNALING 1 GENE; TRANSCRIPTION INITIATION; UPREGULATION;

EID: 0345447641     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.11.5901     Document Type: Article

References (49)

1. Umetsu, D. T., J. J. McIntire, O. Akbari, C. Macaubas, and R. H. DeKruyff. 2002. Asthma: an epidemic of dysregulated immunity. Nat. Immunol. 3:715.
2. Nelms, K., A. D. Keegan, J. Zamorano, J. J. Ryan, and W. E. Paul. 1999. The IL-4 receptor: signaling mechanisms and biologic functions. Annu. Rev. Immunol. 17:701.
3. Corry, D. B. 1999. IL-13 in allergy: home at last. Curr. Opin. Immunol. 11:610.
4. Wills-Karp, M., and M. Chiaramonte. 2003. Interleukin-13 in asthma. Curr. Opin. Pulm. Med. 9:21.
5. Wurster, A. L., T. Tanaka, and M. J. Grusby. 2000. The biology of Stat4 and Stat6. Oncogene 19:2577.
6. Darnell, J. E., Jr. 1997. STATs and gene regulation. Science 277:1630.
7. Delphin, S., and J. Stavnezer. 1995. Characterization of an interleukin 4 (IL-4) responsive region in the immunoglobulin heavy chain germline ε promoter: regulation by NF-IL-4, a C/EBP family member and NF-κB/p50. J. Exp. Med. 181:181.
8. Kotanides, H., and N. C. Reich. 1996. Interleukin-4-induced STAT6 recognizes and activates a target site in the promoter of the interleukin-4 receptor gene. J. Biol. Chem. 271:25555.
9. Kaplan, M. H., U. Schindler, S. T. Smiley, and M. J. Grusby. 1996. Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells. Immunity. 4:313.
10. Takeda, K., T. Tanaka, W. Shi, M. Matsumoto, M. Minami, S.-i. Kashiwamura, K. Nakanishi, N. Yoshida, T. Kishimoto, and S. Akira. 1996. Essential role of Stat6 in IL-4 signalling. Nature 380:627.
11. Linehan, L. A., W. D. Warren, P. A. Thompson, M. J. Grusby, and M. T. Berton. 1998. STAT6 is required for IL-4-induced germline Ig gene transcription and switch recombination. J. Immunol. 161:302.
12. Park, H.-J., E.-Y. So, and C.-E. Lee. 1998. Interferon-γ-induced factor binding to the interleukin-4-responsive element of CD23b promoter in human tonsillar mononuclear cells: role in transient up-regulation of the interleukin-4-induced CD23b mRNA. Mol. Immunol. 35:239.
13. Hoeck, J., and M. Woisetschläger. 2001. Stat6 mediated eotaxin-1 expression in IL-4 or TNF-α-induced fibroblasts. J. Immunol. 166:4507.
14. Hoeck, J., and M. Woisetschlager. 2001. Activation of eotaxin-3/CCL126 gene expression in human dermal fibroblasts is mediated by STAT6. J. Immunol. 167:3216.
15. Stütz, A. M., L. A. Pickart, A. Trifilieff, T. Baumruker, E. Prieschl-Strassmayr, and M. Woisetschläger. 2003. The Th2 cell cytokines IL-4 and IL-13 regulate found in inflammatory zone 1/resistin-like molecule a gene expression by a STAT6 and CCAAT/enhancer-binding protein-dependent mechanism. J. Immunol. 170:1789.
16. Starr, R., T. A. Willson, E. M. Viney, L. J. Murray, J. R. Rayner, B. J. Jenkins, T. J. Gonda, W. S. Alexander, D. Metcalf, N. A. Nicola, and D. J. Hilton. 1997. A family of cytokine-inducible inhibitors of signalling. Nature 387:917.
17. Endo, T. A., M. Masuhara, M. Yokouchi, R. Suzuki, H. Sakamoto, K. Mitsui, A. Matsumoto, S. Tanimura, M. Ohtsubo, H. Misawa, et al. 1997. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387:921.
18. Naka, T., M. Narazaki, M. Hirata, T. Matsumoto, S. Minamoto, A. Aono, N. Nishimoto, T. Kajita, T. Taga, K. Yoshizaki, S. Akira, and T. Kishimoto. 1997. Structure and function of a new STAT-induced STAT inhibitor. Nature 387:924.
19. Kile, B. T., B. A. Schulman, W. S. Alexander, N. A. Nicola, H. M. Martin, and D. J. Hilton. 2002. The SOCS box: a tale of destruction and degradation. Trends Biochem. Sci. 27:235.
20. Hilton, D. J., R. T. Richardson, W. S. Alexander, E. M. Viney, T. A. Willson, N. S. Sprigg, R. Starr, S. E. Nicholson, D. Metcalf, and N. A. Nicola. 1998. Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc. Natl. Acad. Sci. USA 95:114.
21. Nicola, N. A., and C. J. Greenhalgh. 2000. The suppressors of cytokine signaling (SOCS) proteins: important feedback inhibitors of cytokine action. Exp. Hematol. 28:1105.
22. Krebs, D. L., and D. J. Hilton. 2001. SOCS proteins: negative regulators of cytokine signaling. Stem Cells 19:378.
23. Ferguson, P. R., and J. A. Johnston. 2001. Suppressors of cytokine signalling (SOCS) regulate cytokine and growth factor responses in the immune system. Mod. Aspects Immunobiol. 2:92.
24. Alexander, W. S. 2002. Suppressors of cytokine signalling (SOCS) in the immune system. Nat. Rev. Immunol. 2:410.
25. Matsumoto, A., M. Masuhara, K. Mitsui, M. Yokouchi, M. Ohtsubo, H. Misawa, A. Miyajima, and A. Yoshimura. 1997. CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation. Blood 89:3148.
26. Saito, H., Y. Morita, M. Fujimoto, M. Narazaki, T. Naka, and T. Kishimoto. 2000. IFN regulatory factor-1-mediated transcriptional activation of mouse STAT-induced STAT inhibitor-1 gene promoter by IFN-gamma. J. Immunol. 164:5833.
27. Schlüter, G., D. Boinska, and S. C. Nieman-Seyde. 2000. Evidence for translational repression of the SOCS-1 major open reading frame by an upstream open reading frame. Biochem. Biophys. Res. Commun. 268:255.
28. He, B., L. You, K. Uematsu, M. Matsangou, Z. Xu, M. He, F. McCormick, and D. M. Jablons. 2003. Cloning and characterization of a functional promoter of the human SOCS-3 gene. Biochem. Biophys. Res. Commun. 301:386.
29. Davey, H. W., M. J. McLachlan, R. J. Wilkins, D. J. Hilton, and T. E. Adams. 1999. STAT5b mediates the GH-induced expression of SOCS-2 and SOCS-3 mRNA in the liver. Mol. Cell. Endocrinol. 158:111.
30. Emanuelli, B., P. Peraldi, C. Filloux, D. Sawka-Verhelle, D. Hilton, and E. Van Obberghen. 2000. SOCS-3 is an insulin-induced negative regulator of insulin signaling. J. Biol. Chem. 275:15985.
31. Auernhammer, C. J., C. Bousquet, and S. Melmed. 1999. Autoregulation of pituitary corticotroph SOCS-3 expression: characterization of the murine SOCS-3 promoter. Proc. Natl. Acad. Sci. USA 96:6964.
32. Starr, R., D. Metcalf, A. G. Elefanty, M. Brysha, T. A. Willson, N. A. Nicola, D. J. Hilton, and W. S. Alexander. 1998. Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. Proc. Natl. Acad. Sci. USA 95:14395.
33. Cornish, A. L., G. M. Davey, D. Metcalf, J. F. Purton, J. E. Corbin, C. J. Greenhalgh, R. Darwiche, L. Wu, N. A. Nicola, D. I. Godfrey, et al. 2003. Suppressor of cytokine signaling-1 has IFN-γ-independent actions in T cell homeostasis. J. Immunol. 170:878.
34. Andrews, N. C., and D. V. Faller. 1991. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19:2499.
35. Schlüter, G., A. Celik, R. Obata, M. Schlicker, S. Hofferbert, A. Schlung, I. M. Adham, and W. Engel. 1996. Sequence analysis of the conserved protamine gene cluster shows that it contains a fourth expressed gene. Mol. Reprod. Dev. 43:1.
36. Dickensheets, H. L., C. Venkataraman, U. Schindler, and R. P. Donnelly. 1999. Interferons inhibit activation of STAT6 by interleukin 4 in human monocytes by inducing SOCS-1 gene expression. Proc. Natl. Acad. Sci. USA 96:10800.
37. Losman, J. A., X. P. Chen, D. Hilton, and P. Rothman. 1999. Cutting edge: SOCS-1 is a potent inhibitor of IL-4 signal transduction. J. Immunol. 162:3770.
38. Gregorieff, A., S. Pyronnet, N. Sonenberg, and A. Veillette, 2000. Regulation of SOCS-1 expression by translational repression. J. Biol. Chem. 275:21596.
39. Ezernieks, J., B. Schnarr, K. Metz, and A. Duschl. 1996. The human IgE germline promoter is regulated by interleukin-4, interleukin-13, interferon-α and interferon-γ via an interferon-γ-activated site and its flanking regions. Eur. J. Biochem. 240:667.
40. Huang, H., J. Hu-Li, H. Chen, S. Z. Ben-Sasson, and W. E. Paul. 1997. IL-4 and IL-13 production in differentiated T helper type 2 cells is not IL-4 dependent. J. Immunol. 159:3731.
41. Schnyder, B., S. Schnyder-Candrian, A. Panski, H. Bömmel, M. Heim, A. Duschl, and R. Moser. 2002. Phytochemical inhibition of interleukin-4-activated Stat6 and expression of VCAM-1. Biochem. Biophys. Res. Commun. 292:841.
42. Nicholson, S. E., T. A. Willson, A. Farley, R. Starr, J. G. Zhang, M. Baca, W. S. Alexander, D. Metcalf, D. J. Hilton, and N. A. Nicola. 1999. Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction. EMBO J. 18:375.
43. Sasaki, A., H. Yasukawa, A. Suzuki, S. Kamizono, T. Syoda, I. Kinjyo, M. Sasaki, J. A. Johnston, and A. Yoshimura. 1999. Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain. Genes Cells 4:339.
44. Haque, S. J., P. C. Harbor, and B. R. G. Williams. 2000. Identification of critical residues required for suppressor of cytokine signaling-specific regulation of in-terleukin-4 signaling. J. Biol. Chem. 275:26500.
45. Ram, P. A., and D. J. Waxman. 2000. Role of the cytokine-inducible SH2 protein CIS in desensitization of STAT5b signaling by continuous growth hormone. J. Biol. Chem. 275:39487.
46. Foster, P. S. 1999. STAT6: an intracellular target for the inhibition of allergic disease. Clin. Exp. Allergy 29:12.
47. Barnes, P. J. Cytokine-directed therapies for asthma. J. Allergy Clin. Immunol. 108:S72, 2001.
48. Corry, D. B. 2001. Emerging immune targets for the therapy of allergic asthma. Nat. Rev. Drug. Discov. 1:55.
49. Stolzenberger, S., M. Haake, and A. Duschl. 2001. Specific inhibition of interleukin-4 dependent Stat6 activation by an intracellularly delivered peptide. Eur. J. Biochem. 268:4809.